Skip to main content
AIOBIO Co., Ltd. logo

AIOBIO Co., Ltd. — Investor Relations & Filings

Ticker · 447690 ISIN · KR7447690009 KO Manufacturing
Open in API
Filings indexed 88 across all filing types
Latest filing 2025-03-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 447690

About AIOBIO Co., Ltd.

https://www.aiobio.com/

AIOBIO Co., Ltd. is a medical device company specializing in advanced dental care solutions. The company develops and manufactures diagnostic tools and platforms based on its proprietary Biofluorescence-Led Intelligent Screening System (BLISS) technology. Its product portfolio includes imaging devices that provide instant visual analysis for the early detection of oral health issues. AIOBIO's core offering is the LINKDENS platform, an integrated system that connects dental clinics and patients. Powered by AI-driven diagnostics, instant imaging analysis, and remote patient monitoring, LINKDENS streamlines clinical workflows, enhances diagnostic accuracy, and fosters a connected dental care experience for both professionals and patients.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement titled '증권 발행결과' (Securities Issuance Result) regarding the issuance of convertible bonds (전환사채). It details the issuance method, amount, payment date, and settlement method. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2025-03-28 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market. It details the terms of the bond, the purpose of the funds, and the impact on share capital, which aligns perfectly with the 'Capital/Financing Update' category.
2025-03-27 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) which includes a correction notice regarding the classification of a subsidiary. It provides key financial data (assets, liabilities, net income) and audit opinions (적정/Unqualified) as required by regulatory disclosure standards for audit reports. Since it contains the actual audit results and financial summary rather than just an announcement of a report's availability, it is classified as an Audit Report. FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 14th fiscal year (2024) of AIOBIO Co., Ltd. It contains comprehensive company information, including business overview, financial status, management discussion, and governance details. It is a formal, long-form annual filing submitted to the Financial Supervisory Service and the Korea Exchange. It is not an announcement of a report, but the report itself. FY 2024
2025-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short, structured announcement titled '감사보고서 제출' (Submission of Audit Report) dated 2025.03.20. It provides a summary of the audit opinion and key financial figures (assets, liabilities, revenue, etc.) as reported by the external auditor (예일회계법인). According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2024
2025-03-20 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for the 14th Annual General Meeting of AIOBIO Co., Ltd. It includes the meeting date, location, agenda items (financial statement approval, director/auditor appointments, etc.), and detailed management reference materials (governance, board activities, and business overview). This document is a standard proxy statement/notice package sent to shareholders to inform them of the upcoming meeting and solicit their votes. In the context of the provided categories, this aligns with 'Proxy Solicitation & Information Statement'.
2025-03-14 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.